D-0157-2021 Class II Terminated
FDA drug recall D-0157-2021 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Nov 17, 2020 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%. The recall status is terminated (terminated Feb 21, 2024). Affected quantity: 11,088 1 oz tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 23, 2020
- Initiation Date
- Nov 17, 2020
- Termination Date
- Feb 21, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,088 1 oz tubes
Product description
Best Choice, Clotrimazole Cream, USP 1%, Antifungal, NET WT 0.5 OZ (14.2g), Distributed by: Valu Merchandisers, CO . 5000 Kansas Ave. Kansas City, KS 66106 Made in Canada. UPC 0-70038-20355-1
Reason for recall
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
Distribution pattern
Distributed Nationwide in the USA and Canada
Code information
Lot #: D867331087, Exp Mar, 2021 70,200 63,252
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0157-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026